AAAAAA

   
Results: 1-11 |
Results: 11
EVALUATION OF CGP 39393 AS THE ANTICOAGULANT IN CARDIOPULMONARY BYPASS-SURGERY
Authors: PIFARRE R KOZA MJ PARK SJ TERRELL MR KHENKINA Y WALENGA JM
Citation: R. Pifarre et al., EVALUATION OF CGP 39393 AS THE ANTICOAGULANT IN CARDIOPULMONARY BYPASS-SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 1453-1453
PEG-HIRUDIN AS ANTICOAGULANT IN CARDIOPULMONARY BYPASS
Authors: WALENGA JM TERRELL MR KOZA MJ KHENKINA Y FAREED J PIFARRE R
Citation: Jm. Walenga et al., PEG-HIRUDIN AS ANTICOAGULANT IN CARDIOPULMONARY BYPASS, Thrombosis and haemostasis, 73(6), 1995, pp. 1454-1454
THROMBIN INHIBITOR ARGATROBAN AS ANTICOAGULANT IN CARDIOPULMONARY BYPASS-SURGERY
Authors: KOZA MJ WALENGA JM TERRELL MR KHENKINA Y ARCIDI J PIFARRE R
Citation: Mj. Koza et al., THROMBIN INHIBITOR ARGATROBAN AS ANTICOAGULANT IN CARDIOPULMONARY BYPASS-SURGERY, Blood, 86(10), 1995, pp. 349-349
COAGULATION ASSESSMENT AND LABORATORY MONITORING OF PATIENTS GIVEN THE THROMBIN INHIBITOR NOVASTAN(R)
Authors: WALENGA JM KOZA MJ KHENKINA Y BLAKEMORE C LEWIS BE PIFARRE R
Citation: Jm. Walenga et al., COAGULATION ASSESSMENT AND LABORATORY MONITORING OF PATIENTS GIVEN THE THROMBIN INHIBITOR NOVASTAN(R), Blood, 86(10), 1995, pp. 3551-3551
PEG-HIRUDIN AS ANTICOAGULANT IN CARDIOPULMONARY BYPASS
Authors: WALENGA JM TERRELL MR KOZA MJ KHENKINA Y FAREED J PIFARRE R
Citation: Jm. Walenga et al., PEG-HIRUDIN AS ANTICOAGULANT IN CARDIOPULMONARY BYPASS, Blood, 84(10), 1994, pp. 10000072-10000072
EVALUATION OF CGP-39393 AS THE ANTICOAGULANT IN CARDIOPULMONARY BYPASS-SURGERY
Authors: PIFARRE R KOZA MJ HOUCK JP PARK SJ KHENKINA Y GORT E WALLOCK ME WALENGA JM
Citation: R. Pifarre et al., EVALUATION OF CGP-39393 AS THE ANTICOAGULANT IN CARDIOPULMONARY BYPASS-SURGERY, Blood, 84(10), 1994, pp. 10000072-10000072
EFFICACY OF APROTININ WITH VARIOUS ANTICOAGULANTS IN A CANINE MODEL OF CARDIOPULMONARY BYPASS
Authors: TERRELL MR KOZA MJ WALENGA JM KHENKINA Y PIFARRE R
Citation: Mr. Terrell et al., EFFICACY OF APROTININ WITH VARIOUS ANTICOAGULANTS IN A CANINE MODEL OF CARDIOPULMONARY BYPASS, Blood, 84(10), 1994, pp. 10000470-10000470
CAN HEPARIN BE REPLACED BY LMW HEPARIN IN CARDIOPULMONARY BYPASS-SURGERY
Authors: WALENGA JM KOZA M PARK S KHENKINA Y GORT E WOLF H PIFARRE R
Citation: Jm. Walenga et al., CAN HEPARIN BE REPLACED BY LMW HEPARIN IN CARDIOPULMONARY BYPASS-SURGERY, Thrombosis and haemostasis, 69(6), 1993, pp. 935-935
PROGRESSIVE ACCUMULATION OF R-HIRUDIN AFTER REPEATED SUBCUTANEOUS ADMINISTRATION - POTENTIAL IMPLICATIONS IN THE PROPHYLAXIS OF DVT
Authors: KOZA M IYER L KHENKINA Y FASANELLA A WALENGA JM PIFARRE R FAREED J
Citation: M. Koza et al., PROGRESSIVE ACCUMULATION OF R-HIRUDIN AFTER REPEATED SUBCUTANEOUS ADMINISTRATION - POTENTIAL IMPLICATIONS IN THE PROPHYLAXIS OF DVT, Thrombosis and haemostasis, 69(6), 1993, pp. 1301-1301
MONITORING OF THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED RECOMBINANT HIRUDIN IN DOGS
Authors: KHENKINA Y KOZA M WALENGA JM FAREED J PIFARRE R
Citation: Y. Khenkina et al., MONITORING OF THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED RECOMBINANT HIRUDIN IN DOGS, Thrombosis and haemostasis, 69(6), 1993, pp. 1305-1305
COMPARATIVE HEPARIN-INDUCED THROMBOCYTOPENIC RESPONSE WITH LOW-MOLECULAR-WEIGHT HEPARIN AND A SYNTHETIC PENTASACCHARIDE
Authors: PIFARRE R WALENGA JM KOZA MJ KHENKINA Y FAREED J
Citation: R. Pifarre et al., COMPARATIVE HEPARIN-INDUCED THROMBOCYTOPENIC RESPONSE WITH LOW-MOLECULAR-WEIGHT HEPARIN AND A SYNTHETIC PENTASACCHARIDE, Thrombosis and haemostasis, 69(6), 1993, pp. 1319-1319
Risultati: 1-11 |